Charles River Laboratories International (CRL) Net Cash Flow (2009 - 2026)

Charles River Laboratories International has reported Net Cash Flow for 18 years, with the latest figure at $43.2 million in Q2 2026.

• On a quarterly basis, Net Cash Flow rose 172.35% year-over-year to $43.2 million in Q2 2026; TTM through Jun 2026 was $54.5 million, a 744.5% increase from a year earlier, with the FY2025 full-year figure at -$8.4 million, up 86.33% from the prior year.
• Net Cash Flow was $43.2 million for Q2 2026 at Charles River Laboratories International, up from -$19.0 million in the prior quarter.
• The five-year high for Net Cash Flow was $106.1 million in Q4 2023, with the low at -$154.2 million in Q2 2024.
• Average Net Cash Flow over 5 years is -$2.3 million, with a median of $1.4 million recorded in 2023.
• The largest YoY upside for Net Cash Flow was 283.69% in 2024 against a maximum downside of 314771.43% in 2024.
• Over 5 years, Net Cash Flow stood at $30.2 million in 2022, then soared by 251.64% to $106.1 million in 2023, then plunged by 93.05% to $7.4 million in 2024, then plunged by 61.39% to $2.8 million in 2025, then soared by 1414.95% to $43.2 million in 2026.
• The last three Net Cash Flow figures came in at $43.2 million (Q2 2026), -$19.0 million (Q1 2026), and $2.8 million (Q4 2025), per Business Quant data.